IMMUNOVATIVE THERAPIES
Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstanding incubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.
IMMUNOVATIVE THERAPIES
Industry:
Biotechnology Health Care Therapeutics
Founded:
2004-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.immunovative.com
Total Employee:
51+
Status:
Active
Contact:
972-3-9702090
Email Addresses:
[email protected]
Total Funding:
16.5 M USD
Technology used in webpage:
SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Incapsula
Current Advisors List
Current Employees Featured
Founder
Investors List
Trendlines Group
Trendlines Group investment in Venture Round - Immunovative Therapies
Misgav Technology Center
Misgav Technology Center investment in Venture Round - Immunovative Therapies
Malcolm Currie
Malcolm Currie investment in Seed Round - Immunovative Therapies
Office of the Chief Scientist
Office of the Chief Scientist investment in Seed Round - Immunovative Therapies
Trendlines Group
Trendlines Group investment in Seed Round - Immunovative Therapies
